COMPANIES COVERED
Merck & Co., IncDownload FREE Report Sample
Download Free sampleHuman papilloma virus (HPV) vaccines are used to protect against HPV infections.
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
HPV Therapeutic Vaccines Market contains market size and forecasts of HPV Therapeutic Vaccines in global, including the following market information:
Global HPV Therapeutic Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global HPV Therapeutic Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five HPV Therapeutic Vaccines companies in 2021 (%)
The global HPV Therapeutic Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bivalent HPV vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of HPV Therapeutic Vaccines include Merck & Co., Inc, GlaxoSmithKline plc, Shanghai Bovax Biotechnology Co., Ltd., Profectus BioSciences, Inc., 2A Pharma AB and ISA Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the HPV Therapeutic Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HPV Therapeutic Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global HPV Therapeutic Vaccines Market Segment Percentages, by Type, 2021 (%)
Bivalent HPV vaccine
Quadrivalent HPV vaccine
Global HPV Therapeutic Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global HPV Therapeutic Vaccines Market Segment Percentages, by Application, 2021 (%)
Man
Woman
Global HPV Therapeutic Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global HPV Therapeutic Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HPV Therapeutic Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies HPV Therapeutic Vaccines revenues share in global market, 2021 (%)
Key companies HPV Therapeutic Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies HPV Therapeutic Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co., Inc
GlaxoSmithKline plc
Shanghai Bovax Biotechnology Co., Ltd.
Profectus BioSciences, Inc.
2A Pharma AB
ISA Pharmaceuticals
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
